** Medical device maker Insulet's PODD.O shares rise 10.2% to $283.20 premarket
** Insulet late on Thursday beat Q1 profit estimates, buoyed by strong demand for its wearable insulin pumps
** Company earned $1.02 per share, above analysts' average estimate of 80 cents per share - data compiled by LSEG
** Company now expects its annual revenue to grow between 19% and 22%, compared with its previous projection of 16% to 20%
** Company's Q1 total revenue increased 28.8% to $569 million, compared with analysts' estimates of $543.4 million
** As of last close, stock down 1.6% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.